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Tall stature is defined as height above 97th percentile for
age and sex or more than 2SD above the mean for a
defined population. It means 3 out of every 100 children
in a community are tall and should be evaluated.
Familial tall stature also known as constitutional tall
stature is the most common cause of tall stature. The
height is consistently above 97th percentile percentile and
mid paretal height too is above 90th or 97th percentile.
Usually occurs in a female child and the mother often
remembers her unusual tall stature during her childhood.
The bone as is marginally to moderately advanced so that
the final height prediction is not very heigh. Physical
examination is normal and lab tests, if obtained, are
negative.
The second most common cause of tall stature is
nutritional. The height as well as the weight are at
higher percentile. Again the bone age is maginally to
moderately advanced so that final predicted adult height
is not too much.
Hormonal causes of tall stature include hyperthyroidism,
precocious puberty and growth hormone excess.
Hyperthyroidism is more common in girls and is almost
always caused by Grave’s disease.The bone age is moder-
ately advanced so that the final adult height is usually
compromised.
In cases of precocious puberty, although due to ana-
bolic effects of sex steroids, the child is tall at the onset,
the ultimate adult height is compromised due to prema-
ture epiphyseal fusion caused by oestrogen. Again,
although, delayed puberty may be associated with short
stature in childhood, as with constitutional delay, failure to
eventually enter puberty and complete sexual maturation
may result in sustained growth in adult life, with ultimate
tall stature [1].
GH hormone excess causes gigantism in childhhod and
acromegaly in adults. Gigantism is characterized by tall
stature, broad hands and feet, prognathism, broad root of
nose, excessive sweating, hypertension and glucose intoler-
ance. Almost each and every part of the body is affected
and large for age. GH levels are consistently high and can
exceed 100 ng/ml [2]. Serum IGF-1 and IGFBP-3 are
raised and serve as a sensitive screening tool for GH
excesses. But the gold standard for making the diagnosis
of GH excess is the failure to suppress serum GH levels
below 5 ng /dl after 1.75 gm/ kbw glucose challange. This
test measures the ability of IGF-1 to suppress GH secre-
tion, because the glucose load results in insulin secretion,
leading to suppression of IGFBP-1 which results in an
acute increase in serum free IGF-1 level.
There are some important chromosomal and syndromic
causes of tall stature in children. Klinefelter’s syndrom
(XXY) is the commonest chromosomal disorder affecting
males (in 500-1000 boys). It should be suspected in boys
with delayed puberty with tall stature, small and firm
testes, eunochoid body proportions (decreased U/L seg-
ment) and gynaecomastia. And if these features are
accompanied by delayed bone age it is almost diagnostic
of Klinefelter syndrom. Serum levels of LH and FSH are
raised and serum testosterone is markedly diminished.
Homocystinuria is an autosomal recessive inborn error
of aminoacid metabolism due to deficiency of cystathio-
nine synthase. The gene is located on chromosom 21.
It is characterized by tall stature, arachnodactyly, mental
retardation and various occular manifestations. There is
characteristic inferior subluxation of lens. Lab investiga-
tion includes positive cyanide nitroprucide test in urine
as well as presence of homocystein in the urine. This
condition is to be differentiated from Marfan syndrom
which is characterized by defective fibrillin gene on chro-
mosom 15, resulting in abnormal synthesis of fibrillin, a
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that provide scaffolding network of elastic fibres and have
an anchoring function in non- elastic tissues such as aortic
adventitia and suspensory ligaments of lens. Unlike homo-
cystinuria there is no mental retadation and the subluxa-
tion of lens is upwards.
Sotos syndrom or cerebral gigantis is a non- endocrine
condition of overgrowth which is characterized by large
weight as well as height. The overgrowth continues even
after birth so that by first birth day affected inants are
greater than 97th percentile for height. Rapid growth con-
tinues till 4-5 years of age and then returns to the normal
rate. The bone is advanced so the final adult height is in
the upper normal range. There is no distinctive lab or
radiological markers for the disease. Serum GH and IGF-1
levels are within normal limits.
Beckwith-weidman syndrome is a foetal overgrowth syn-
drome that is characterized by macrocephaly, macroglos-
sia, omphalocoele, hepatosplenomegaly and hypoglycemia
secondary to pancreatic B cell hyperplasia. In some cases,
duplication of paternal IGF-2 gene with overexpression of
IGF-2 has been seen [3]. Adult height is usually within
normal range due to concomitant increase in bone age.




• Bone age assessment and prediction of final height.
Special investigations include:
• Serum LH, FSH and testosterone levels
• Glucose suppression test for GH
• Vsual field examination
• MRI of pituitary
• Serum cortisol
• Serum prolactin
Management of tall stature
Constitutional tall stature requires only reassurance after
bone age assesment and prediction of final height.
Obstinate cases require sex steroids to halt the progres-
sion of growth. In girls ethinylestradiol orally combined
with cyclic progesterone has shown to reduce the final
height upto 7 c.m.In boys testosterone 250-1000 mg
monthly has shown simillar results.For best results these
drugs should be started early i.e before 10 years in girls
and 12.5 years in boys [4].
Nutritional tall stature is managed by life-style changes
and avoidance of bad dietary practices.
Thyrotoxicosis is maned by use of antithyroid drugs.
Methimazole and carbimazole are two commonly used
antithyroid drugs.
Octreotides are somatostatin analogoues which can
be used at a dose of 37.5-50 mg once or twice daily
subcutaneously to reduce growth hormone hypersecretion
and it has shown to reduce the final height upto 5cm [5].
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